March 2004

  

"ISPOR e-BULLETIN" provides updates of recent ISPOR activities and events. For detailed information on ISPOR activities, members are encouraged to go to www.ispor.org.

 

Please pass these updates along to your colleagues.

 


In this issue:

 

1.        Publications (Value in Health, ISPOR CONNECTIONS, HEALTH CARE COST, QUALITY, AND OUTCOMES:  ISPOR Book of Terms)

2.        Meetings and Congresses

3.        Educational Activities

4.        Student News

5.        ISPOR Special Interest Groups

6.        Committee and Task Force Activities

7.        Hot Topics

8.        Important Dates to Remember

9.        Employment in Pharmacoeconomics and Outcomes Research

10.      Membership

 

ANNOUNCEMENT

 

In Memoriam - Bernie O’Brien

 

It is with great sadness to inform you that Bernie O'Brien PhD died suddenly on Friday, February 13th. He is survived by his wife, Karen, and two daughters, Emma and Lucy.

 

Bernie was Chair of the ISPOR 9th Annual International Meeting to be held in May this year in Arlington, VA, USA. He also was a recipient of the 2002 ISPOR Research Excellence Award for Methodology Excellence. He actively participated in ISPOR activities such as co-author of the "Principles of Good Practice for Decision Analytic Modeling in Health-Care Evaluation: Report of the ISPOR Task Force on Good Research Practices - Modeling Studies"

 

He will be greatly missed.

 


 

  1. PUBLICATIONS

Top

 

VALUE IN HEALTH

 

Value in Health: Volume 7, Issue 1, January/February 2004 is available online at:

 

http://www.ispor.org/valueinhealth_index.asp

 

Featured in this issue…

 

"Outcomes Research in Health Care: Simulations to Drive Cost Conclusions" a commentary by Raulo Frear, Brenda Motheral

 

Value in Health: Volume 7, Issue 2, March/April 2004 will be available to the public and online later this month.  Featured in the upcoming issue . . .

 

“ISPOR Scientific Report: ISPOR Code of Ethics for Researchers Background Article–Report of the ISPOR Task Force on Code of Ethics for Researchers” by Francis B. Palumbo, PhD, JD, Rod Barnes, MBA, Patricia Deverka, MD, MS, William McGhan, PharmD, PhD, Lawrence Mullany, MD, MBA, Albert Wertheimer, MBA, PhD

 

ISPOR CONNECTIONS

 

ISPOR CONNECTIONS: Volume 10, Issue 1, January/February 2004 is now available online at: http://www.ispor.org/news/index_new.asp

 

Feature Article...

 

"Bridging the Gap" - Relating Patient Reported Outcomes (PROs) to Decision-Makers by Michael Edmondson, PhD, Consumer Health Sciences, Princeton, NJ, USA

 

ISPOR CONNECTIONS: Volume 10, Issue 2, March/April 2004 will be available to the public and online next month.  Featured in the next issue . . .

 

“Measuring the Gains from Medical Research: An Economic Approach”.  This introduction taken from the book edited by Kevin M. Murphy and Robert H. Topel in 2003.

 

All technical articles are exclusive to MEMBERS!  You just need your e-mail address and your member ID number to view the entire text when prompted.

 

We are now also accepting submissions for the news journal as well on-line at http://www.ispor.org/news/index_new.asp for complete submission guidelines!

 

HEALTH CARE COST, QUALITY, AND OUTCOMES: ISPOR BOOK OF TERMS

 

This ISPOR publication includes over 100 monographs covering over 400 terms used in health care delivery, management, and regulation, as well as health care outcomes research including clinical, economic, and quality-of-life research terms. ISPOR member discounted price is $36.00; a 40% discount!  Student/Library/Academic discounted price: $33.00 (a 45% discount). On-line ordering now available at: http://www.ispor.org/publications/lexicon_index.asp.  Contact Stephen Priori at spriori@ispor.org for information on orders over 100 and book sponsorship.

 

NOW LISTED ON BARNESANDNOBLE.COM AND AMAZON.COM!

 

HEALTH CARE COSTS, QUALITY, AND OUTCOMES: ISPOR Book of Terms is now on the internet’s leading on-line book sellers.  If you or a colleague have received the book and would like to recommend it to others, you can write a review or recommendation on each of the websites.  Go to http://www.barnesandnoble.com, and do a title search for “ISPOR Book of Terms”, or go to http://www.amazon.com, and do a book search under “ISPOR”.

 


 

  1. ISPOR MEETINGS AND CONGRESSES

Top

  

9TH ANNUAL INTERNATIONAL MEETING

 

9TH Annual International Meeting: May 16-19, 2004, Crystal Gateway Marriott, Arlington, VA, USA

 

All accepted podium and posters presentations are now at the ISPOR website.  For more information, see program at: http://www.ispor.org/meetings/va0504/index.asp

 

This year’s program features:

 

  • 3 Plenary Sessions

         Medicare Drug Benefit & Cost-Effectiveness: Who Plays & Who Pays

         New Directions In Risk Sharing And Post Marketing Economic Evaluation

         The $64,000 Question:  What Are We Willing To Pay For A Qaly?

 

Annual Meeting Early Registration Deadline: Tuesday, April 20, 2004 https://www.ispor.org

 

ISPOR PRE-MEETING SYMPOSIUM

 

Benefit/Risk:  In Search of the Proper Balance

Sunday, May 16, 2004, 5:00PM-7:00PM

Crystal Gateway Marriott, Arlington, VA, USA

Prior to the ISPOR 9th Annual International Meeting

Co-Sponsored by ISPOR and PhRMA Health Outcomes Committee

 

The majority of activity regarding risk/benefit has centered around the qualification and measurement of risk and potential system changes in reporting of risk.  Important for consideration in this equation are the adverse health consequences that result from not using medicines properly, i.e. benefits foregone. In addition, the FDAMA- mandated Centers for Education and Research in Therapeutics have conducted and disseminated results from a landmark series of think tanks on risk in the context of benefit.  This session will provide an overview of the current environment, discuss a pharmaceutical industry case study and provide one government agency's approach to addressing benefit/risk.

 

Please see http://www.ispor.org/meetings/va0504/111604.asp for symposium program.

 

7TH ANNUAL EUROPEAN CONGRESS

 

7TH Annual European Congress: 24-26 October 2004, CCH Congress Centrum Hamburg, Hamburg, German

 

ABSTRACT SUBMISSIONS NOW BEING ACCEPTED AT:

Abstract Deadline: 21 June 2004

 

 

 


 

  1. EDUCATION ACTIVITIES

Top

 

PUBLISH ISPOR RESEARCH PRESENTATION ON THE ISPOR WEBSITE

ISPOR initiated publishing contributed research presentations starting with the ISPOR 4th Annual European Congress, November 2001. The contributed research presentations pages contain poster and podium presentations (as PDF files) from authors who have agreed to post their findings on the ISPOR website. There are over 500 contributed research presentations on-line.  All presentations are available for ISPOR members only.  To view ISPOR poster/podium presentations on the ISPOR website or to submit YOUR research presentation, please go to this link: http://www.ispor.org/research_pdfs/research_index.asp

 

ISPOR LEARNING OUTCOMES TASK FORCE

The objective of the ISPOR Learning Outcomes Task Force is to develop learning outcomes in the area of pharmacoeconomics and outcomes research (i.e. which standard set of skills and knowledge to be trained in this field).  All Task Force members should have received a survey asking for your support in revising their current list of audiences and skills/knowledge and to answer questions about the list. If you are a Task Force member, or interested in responding to this survey, e-mail your request or response to laugustyniak@ispor.org.

 

SHORT COURSES- ISPOR 9TH ANNUAL INTERNATIONAL MEETING

18 ISPOR SHORT COURSES will be held prior to the ISPOR 9th Annual International Meeting in May. For description information please go to this link: http://www.ispor.org/meetings/va0504/index.asp

 

Saturday, May 15 Courses:

 

Pharmacoeconomics

  • Pharmacoeconomics for Decision-makers (full-day course)

Modeling

  • Modeling: Structure & Design of Model (full day course)

Quality of Life / Patient-reported Outcomes

  • Introduction to Quality of Life / Patient-reported Outcomes  (AM)
  • Quality of Life / Patient-reported Outcomes in Clinical Trials  (PM)

Economic Analysis

  • Cost Estimation: Finding and Extracting Cost Data  (AM)
  • Financial Impact / Cost of Illness  (PM)

Clinical Assessment

  • Introduction to Pharmacoepidemiology  (AM)
  • Randomized Clinical Trial and Observational/Naturalistic Study Design (PM)

 

Sunday, May 16 Courses:

 

Pharmacoeconomics

  • Elements of Pharmaceutical Pricing (PM)

Modeling

  • Bayesian Analysis: Overview (AM)
  • Bayesian Analysis: Applications (PM)

Quality of Life / Patient-reported Outcomes

  • Advanced Quantitative Methods for Quality of Life / Patient-reported Outcomes Research (AM)
  • Old and New Utility Measures in Health Economics and Outcomes Research (PM)

Economic Analysis

  • Statistical Considerations In Economic Evaluations (PM)

Clinical Assessment

  • Retrospective Database Analysis: Data sources and Methods (full day course)
  • Meta-Analysis And Systematic Literature Review  (AM)

Decision Analysis

  • Introduction To Decision Analysis (AM)
  • Computer-Assisted Decision Analysis Applications (PM)

 

 


 

  1. STUDENT NEWS

Top

NEW: Student Travel Grants! ISPOR Student Travel Grants will be provided on a competitive basis to students based on sponsorship availability for the ISPOR Annual International Meeting and the ISPOR European Congress. If you are an employer and interested in sponsoring a student grant or if you are a student and interested in applying for a student travel grant, please contact: travelgrant@ispor.org. Applications will be available on the ISPOR website shortly.

 


 

  1. ISPOR SPECIAL INTEREST GROUPS (SIG)

Top

 

MANAGED CARE_PBM SIG

Research Network Communication Short Survey

Thanks to all members who responded to the ISPOR Research Network Communications Short Survey.  If you haven’t given us your feedback, there is still time.  Email your reply or request to have the survey emailed to you at: mcpbmsig@ispor.org. The results of this survey will be published in ISPOR CONNECTIONS and a summary published in the next ISPOR eBulletin.

http://www.ispor.org/sigs/rm.asp

 

MEDICATION COMPLIANCE SIG

Members of the Medication Compliance SIG will be presenting four contributed workshops, compliance: W2; Measurement & Health Impact; W10: Determining & Analyzing Appropriate on Medication Measures, w18; Issues & Methods Consensus; and W26: Education Issues.  For more details, see: http://www.ispor.org/meetings/va0504/workshops.asp

 

PATIENT REGISTRIES SIG

CLINICAL PRACTICE SIG

Thanks to all ISPOR members who joined these NEW SIGs.  

 

RISK MANAGEMENT SIG

For details on objectives, chair people, to join or to sign up for a working group, please see the ISPOR website at: http://www.ispor.org/sigs/sigsindex.asp

 

Special Interest Group membership is open to ALL ISPOR members.

To JOIN any SIG: http://www.ispor.org/sigs/joinsig.htm

 


 

  1. ISPOR COMMITTEE AND TASK FORCE ACTIVITIES

Top

 

ISPOR VISION 2010 COMMITTEE

The Committee will be drafting the ISPOR VISION 2010 document March 11-13, 2004 in Brookline, MA.  This document will set the direction for ISPOR for the second half of this decade.

 

ISPOR RANDOMIZED TRIAL-COST EFFECTIVENESS ANALYSIS (RCT-CEA) TASK FORCE

The Task Force on Randomized Clinical Trial - Cost Effectiveness Studies was initiated to develop a document on best practices for designing, conducting, and reporting cost-effectiveness analyses alongside clinical trials. The Task Force is co-chaired by Scott Ramsey, Fred Hutchinson Cancer Research Center and Richard Willke, Pfizer, Inc. The Core Group members are: Andrew Briggs, Oxford University; Ruth Brown, MEDTAP; Martin Buxton, Brunel University; Anita Chawla, Genentech; John Cook, Merck; Henry Glick, Univ. of Pennsylvania; Jens Grueger, Novartis; Bengt Liljas, AstraZeneca; Diana Petitti, Kaiser Permanente; and Shelby Reed, Duke University. If you are interested in participating on this Task Force Reference Group, who will review the draft document, please email your interest to: rctcea@ispor.org

 


 

  1. HOT TOPICS

Top

 

PRESIDENT BUSH TO NAME FDA'S MCCLELLAN AS NEW CMS HEAD

President Bush formally announced plans to nominate Food and Drug Administration (FDA) Commissioner Mark McClellan, M.D., Ph.D., as the new Administrator of the Centers for Medicare and Medicaid Services (CMS).

 

For full text of the article, go to: http://www.whitehouse.gov/news/releases/2004/02/20040220.html

 


 

  1. IMPORTANT DATES TO REMEMBER

Top

MARCH 15, 2004 - Nominations deadline for ISPOR Avedis Donebedian Outcomes Research Lifetime Achievement Award. http://www.ispor.org/awards/index_.asp

Submit nominations to awards@ispor.org.

 

APRIL 7, 2004 – Deadline to submit ads to be included in the final program brochure of the ISPOR 9th Annual International Meeting. For more information, go to http://www.ispor.org/meetings/va0504/finprogadv.asp

 


 

  1. EMPLOYMENT

Top

 

WEB PAGE

Fifteen new positions in the employment section this last month. For more information go to: http://www.ispor.org/employment/employment_index.htm

 

ISPOR PRAP CENTER

The ISPOR Professional Recruitment Assistance Program (PRAP) Center at the ISPOR 9th Annual International Meeting May 16-19, 2004 in Arlington, VA, is a targeted, efficient, and cost-effective means to reach qualified candidates (If you would like your job description to be printed in the Final Program, formatted quarter page ad must be received by April 7, 2004).  For more information, go to:  Careers 

 


 

  1. ISPOR MEMBERSHIP

Top

Update your email address at membership@ispor.org! Your email address is required as part of your log in information in the members only section of the ISPOR website.